Cision PR Newswire

CARsgen Presents First Clinical Data on Its In Vivo CAR-T Product Candidate CT1182

SHANGHAI, Nov. 22, 2026 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, announces the clinical data...

Mafengwo AI Intelligent Application Integrates with DeepSeek Model, Leading the Intelligent Transformation of the Tourism Industry

BEIJING, Feb. 13, 2025 /PRNewswire/ -- As DeepSeek's cutting-edge technology rapidly expands across industries, Mafengwo announced the integration of its self-developed AI application with...

A New Japanese Cultural Experience by Isetan Shinjuku

Experience Japanese Culture with All Five Senses at the "JAPAN SENSES" Campaign – A Limited-Time Event Showcasing works that embody a uniquely Japanese...

Akeso Announced Enrollment of First Patient in Phase 3 Trial of Cadonilimab for Consolidation Therapy After Concurrent or Sequential Chemoradiotherapy in NSCLC

HONG KONG, Feb. 13, 2025 /PRNewswire/ -- Akeso, Inc. (9926. HK) ("Akeso" or the "Company") announced the recent completion of the first patient enrollment in...

KALiNA Power and Crusoe Sign Framework Agreement for Joint Development of Multiple Co-Sited AI Data Centre Projects in Alberta

Framework for joint development of multiple Crusoe AI focused data centres co-sited with KALiNA's near-zero-emissions natural gas-fired power plants using carbon...